Stay updated with breaking news from David Bredt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rapport Therapeutics, Inc. (RAPP) expects to raise $136 million in an initial public offering (IPO) on Friday, June 7th, IPO Scoop reports. The company will be issuing 8,000,000 shares at $16.00-$18.00 per share. Rapport Therapeutics, Inc. has a market cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for […]
Rapport Therapeutics, Inc. (RAPP) expects to raise $136 million in an IPO on Friday, June 7th, IPO Scoop reports. The company will be issuing 8,000,000 shares at a price of $16.00-$18.00 per share. Rapport Therapeutics, Inc. has a market-cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for the […]
Rapport Therapeutics, Inc. (RAPP) is planning to raise $136 million in an IPO on Friday, June 7th, IPO Scoop reports. The company plans to issue 8,000,000 shares at a price of $16.00-$18.00 per share. The company has a market-cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for the […]
The new year burst of biotech IPOs may have sputtered out months ago, but Rapport is a reminder that companies are still willing to test the waters
Scientists are calling for stage 3 clinical trials of an Alzheimer's drug to be scrapped after a report highlighted serious doubts about the legitimacy of research that helped the medicine reach that stage.